Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study - Concepedia

Concepedia

Publication | Open Access

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

DOI Full Paper Access

460

Citations

22

References

2010

Year

Dirk J. Lok, Peter van der Meer, Pieta W. Bruggink‐André de la Porte, Erik Lipšic, Jan van Wijngaarden, Hans L. Hillege, Dirk J. van Veldhuisen

Clinical Research in Cardiology

Abstract

Plasma galectin-3 is a novel prognostic marker in patients with chronic HF. Its prognostic value is independent of severity of HF, as assessed by NT-proBNP levels, and it may potentially be used in the management of such patients.

References

	Year	Citations

Page 1